Howard L. Levine

Howard L. Levine brings extensive Chemical Manufacturing and Controls (CMC) technical and regulatory experience to his role as CEO Advisor. Dr. Levine is currently the National Leader of the BioProcess Technology Group, a part of the life sciences practice of BDO USA, LLP, a professional services company. He is a pioneer and thought leader in the biopharmaceutical industry with extensive strategic and operational experience in biopharmaceutical product development and commercialization. In his 40 years in the biopharmaceutical industry Dr. Levine has assisted numerous companies in developing biological products, provided strategic input in the development of new manufacturing technologies, and participated in the successful commercialization of several of these products. In 1994, Dr. Levine founded BioProcess Technology Consultants (BPTC), a leading consulting company that provided integrated strategic, technical, and regulatory advice on biopharmaceutical product development to a broad range of companies. He served as President, and CEO of BPTC until its acqusition by BDO in 2019. Prior to founding BPTC, Dr. Levine was Vice President of Manufacturing Operations at Repligen Corporation and previously held positions of increasing responsibility in process development and manufacturing at Genentech, Amgen, and Xoma. Dr. Levine is a frequently invited lecturer on manufacturing strategy, downstream processing, and commercialization of biotechnology products and an author of numerous, peer-reviewed publications. He holds a Ph.D. in chemistry from the University of Chicago and completed a post-doctoral fellowship at Harvard University.